annual FCF:
-$159.24M-$17.99M(-12.74%)Summary
- As of today (September 17, 2025), NAMS annual free cash flow is -$159.24 million, with the most recent change of -$17.99 million (-12.74%) on December 31, 2024.
- During the last 3 years, NAMS annual FCF has fallen by -$129.70 million (-439.13%).
- NAMS annual FCF is now -1624.66% below its all-time high of $10.44 million, reached on December 31, 2022.
Performance
NAMS Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
-$37.76M-$1.27M(-3.49%)Summary
- As of today (September 17, 2025), NAMS quarterly free cash flow is -$37.76 million, with the most recent change of -$1.27 million (-3.49%) on June 30, 2025.
- Over the past year, NAMS quarterly FCF has increased by +$16.43 million (+30.32%).
- NAMS quarterly FCF is now -6487.92% below its all-time high of $591.10 thousand, reached on December 31, 2021.
Performance
NAMS quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$124.30M+$16.43M(+11.67%)Summary
- As of today (September 17, 2025), NAMS TTM free cash flow is -$124.30 million, with the most recent change of +$16.43 million (+11.67%) on June 30, 2025.
- Over the past year, NAMS TTM FCF has dropped by -$15.13 million (-13.86%).
- NAMS TTM FCF is now -96185.05% below its all-time high of -$129.10 thousand, reached on June 30, 2022.
Performance
NAMS TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
NAMS Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -12.7% | +30.3% | -13.9% |
| 3 y3 years | -439.1% | -10000.0% | -10000.0% |
| 5 y5 years | -2063.9% | - | - |
NAMS Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -1624.7% | at low | <-9999.0% | +31.3% | <-9999.0% | +21.9% |
| 5 y | 5-year | -1624.7% | at low | -6487.9% | +31.3% | <-9999.0% | +21.9% |
| alltime | all time | -1624.7% | at low | -6487.9% | +31.3% | <-9999.0% | +21.9% |
NAMS Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$37.76M(+3.5%) | -$124.30M(-11.7%) |
| Mar 2025 | - | -$36.48M(-2.7%) | -$140.73M(-11.6%) |
| Dec 2024 | -$159.24M(+12.7%) | -$37.48M(+198.0%) | -$159.24M(+30.8%) |
| Sep 2024 | - | -$12.58M(-76.8%) | -$121.75M(+11.5%) |
| Jun 2024 | - | -$54.19M(-1.5%) | -$109.17M(+98.5%) |
| Mar 2024 | - | -$54.99M(+72.5%) | -$54.99M(+70.3%) |
| Dec 2023 | -$141.24M(-1452.4%) | - | - |
| Mar 2023 | - | -$31.87M | -$32.28M |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | $10.44M(-135.4%) | - | - |
| Sep 2022 | - | -$239.90K(+39.0%) | -$215.10K(+66.6%) |
| Jun 2022 | - | -$172.60K(-56.2%) | -$129.10K(-60.8%) |
| Mar 2022 | - | -$393.70K(-166.6%) | -$329.60K(+138.2%) |
| Dec 2021 | -$29.54M(+301.4%) | $591.10K(-484.1%) | -$138.40K(-81.0%) |
| Sep 2021 | - | -$153.90K(-58.8%) | -$729.50K(+26.7%) |
| Jun 2021 | - | -$373.10K(+84.2%) | -$575.60K(+184.2%) |
| Mar 2021 | - | -$202.50K | -$202.50K |
| Dec 2020 | -$7.36M | - | - |
FAQ
- What is NewAmsterdam Pharma Company N.V. annual free cash flow?
- What is the all time high annual FCF for NewAmsterdam Pharma Company N.V.?
- What is NewAmsterdam Pharma Company N.V. annual FCF year-on-year change?
- What is NewAmsterdam Pharma Company N.V. quarterly free cash flow?
- What is the all time high quarterly FCF for NewAmsterdam Pharma Company N.V.?
- What is NewAmsterdam Pharma Company N.V. quarterly FCF year-on-year change?
- What is NewAmsterdam Pharma Company N.V. TTM free cash flow?
- What is the all time high TTM FCF for NewAmsterdam Pharma Company N.V.?
- What is NewAmsterdam Pharma Company N.V. TTM FCF year-on-year change?
What is NewAmsterdam Pharma Company N.V. annual free cash flow?
The current annual FCF of NAMS is -$159.24M
What is the all time high annual FCF for NewAmsterdam Pharma Company N.V.?
NewAmsterdam Pharma Company N.V. all-time high annual free cash flow is $10.44M
What is NewAmsterdam Pharma Company N.V. annual FCF year-on-year change?
Over the past year, NAMS annual free cash flow has changed by -$17.99M (-12.74%)
What is NewAmsterdam Pharma Company N.V. quarterly free cash flow?
The current quarterly FCF of NAMS is -$37.76M
What is the all time high quarterly FCF for NewAmsterdam Pharma Company N.V.?
NewAmsterdam Pharma Company N.V. all-time high quarterly free cash flow is $591.10K
What is NewAmsterdam Pharma Company N.V. quarterly FCF year-on-year change?
Over the past year, NAMS quarterly free cash flow has changed by +$16.43M (+30.32%)
What is NewAmsterdam Pharma Company N.V. TTM free cash flow?
The current TTM FCF of NAMS is -$124.30M
What is the all time high TTM FCF for NewAmsterdam Pharma Company N.V.?
NewAmsterdam Pharma Company N.V. all-time high TTM free cash flow is -$129.10K
What is NewAmsterdam Pharma Company N.V. TTM FCF year-on-year change?
Over the past year, NAMS TTM free cash flow has changed by -$15.13M (-13.86%)